Market Recap — March 18, 2026

Micron Forecasts Robust Revenue on AI Demand; Shares Dip on Hefty Capex Boost

Reviva Pharma Prices $10M Offering at $1.50/Unit, Shares & Warrants to Fund R&D

Investment Group Discloses 41.44% Stake in Infinity Natural Resources via $275M Preferred Stock Purchase

Teads Proposes Reverse Stock Split (1-for-5 to 1-for-25) to Avoid Nasdaq Delisting

Republic Airways Reports Strong 2025 Results Driven by Mesa Merger and New United Airlines CPA

Purple Biotech Reports $26.5M Net Loss Driven by $20.5M Asset Impairment; CEO to Step Down Amidst Financial Challenges

Auditor Expresses Substantial Doubt on Artius II Acquisition's Ability to Continue as Going Concern

CEMPACASMAYO Rebuts Regulator's Allegations of False Financials and Legal Violations Amidst Holcim Expense Dispute

COPEL Secures 15-Year Capacity Reserve Contracts for Hydro Plants, Boosting Long-Term Revenue

Director-Affiliated Entity Sells Over $10 Million in American Public Education Stock

Vaxcyte's VAX-31 Phase 1/2 Data Published in Lancet, Demonstrating Superiority to PCV20 for Key Serotypes

Vice Chairperson Nordhagen Commits 8.43% Stake to Support Public Storage Merger

Bitmine Immersion Technologies Executes $77M Open Market Purchase in Eightco Holdings

10% Owner Buys Over $2.1 Million in Expensify Stock Near 52-Week Lows

CEO Wyatt John T. Buys $3.17M in KLC Shares, Signaling Confidence Post-Losses

10% Owner Chernett Jorey Makes Significant $615K Open Market Purchase in Neuronetics

CEO Seth Lederman Buys $223K in Shares Following Going Concern Warning

Director William Snider Buys Over $103K in Harvard Bioscience Stock Post-Reverse Split

Director Stephen Denelsky Buys $48.7K in Stock, Joining Recent Insider Accumulation

Director Larry Swets Jr. Increases Stake with $37K Open Market Purchase Following Public Offering

10% Owner Continues Significant Share Sales in PBF Energy, Divesting Over $28.8M

Warner Bros. Discovery Global Streaming CEO Sells $18 Million in Stock Amidst Acquisition Agreement

Director-Affiliated Entity Sells Over $10 Million in American Public Education Stock

Lazard CEO Peter Orszag Increases Net Holdings Through Option Exercise and Pre-Planned Sales

COO Mark Romaine Sells Over $740K in Company Stock

Director & 10% Owner Sells $112K in Shares Amidst Going Concern Warning

CEO Sells Shares Amidst Going Concern Warning and Delisting Threat

Micron Forecasts Robust Revenue on AI Demand; Shares Dip on Hefty Capex Boost

Reviva Pharma Prices $10M Offering at $1.50/Unit, Shares & Warrants to Fund R&D

Vaxcyte's VAX-31 Phase 1/2 Data Published in Lancet, Demonstrating Superiority to PCV20 for Key Serotypes

Digital Brands Group enters highly dilutive consulting deal with make-whole guarantee and significant cash commitment

Sports Entertainment Gaming Global Corp Secures Up to $11.76M in Highly Dilutive Convertible Notes

Independent Bank Corp to Acquire HCB Financial for $70.2M, Projecting 6% EPS Accretion

Artelo Biosciences Secures $310K in Highly Dilutive Bridge Financing Amidst Going Concern

Glimpse Group Receives Nasdaq Delisting Notice for Minimum Bid Price Deficiency

Shareholders Approve Massive Dilution, Reverse Stock Split, and Redomestication

SEALSQ Reports 66% FY25 Revenue Growth to $18M, $30-40M Net Loss, $425M Cash

Officer Files Intent to Sell Over $4 Million in Shares Near 52-Week High

CEO Files Intent to Sell $1.76M in Atlas Lithium Shares, Following Prior Disclosure of Insider Selling Plans

Officer/Director Entity Files Form 144 for $113.9M Share Sale, Continuing Recent Dispositions

Officer/Director James Marcelli Files Intent to Sell Additional 250,000 Shares

Officer Files Intent to Sell $9.3M in Venture Global Stock

Director Dean C. Kehler Files Intent to Sell Additional Shares Amidst Ongoing Insider Sales

Director Dean C. Kehler Files Another Intent to Sell Shares, Bringing Total Recent Sales to Over $612K Amidst Company Struggles

CEO Robert Eifler Files Intent to Sell $4.67 Million in Company Stock

Major Shareholder Files Intent to Sell Significant Preferred Stock Amidst Financial Distress

Officer Files Intent to Sell $4.99M in Infinity Natural Resources Shares